Terveystalo Oy Class A · OMXHEX:TTALO

Terveystalo Oy Class A — Q1 2021 Earnings Presentation

24 slides from Terveystalo Oy Class A's earnings presentation, 2021

  1. Slide 1: Terveystalo Q1/2021 results: Revenue increased and result improved clearly

    Terveystalo Q1/2021 results: Revenue increased and result improved clearly driven by corporate customers CEO Ville lho CFO IIkka Laurila

  2. Slide 2: Strong growth in revenue, profitability growth accelerated

    COVID-19 TESTS DURING Q1 STRONG GROWTH IN REVENUE PROFITABILITY GROWTH CUSTOMER SATISFACTION AT ACCELERATED RECORD HIGH LEVEL Revenue increased by 8.3% to Adjusted EBITA increased by Net Promoter Score (NPS) for EUR 278.7 (257,4) million. 66.6% to EUR 38.2 (22.9) million appointments improved clearl

  3. Slide 3: Q1/21 revenue by payer group, M€

    Q1/21 revenue by payer group, M€ • Revenue increased in all customer groups 8.3% • Appointments associated with various infections 300 279 remained at low level 257 23 250 16 21 • Demand for specialist appointments was nearly 21 flat y-o-y 29 200 29 • Demand for well-being services remained strong:

  4. Slide 4: Market and share growth, share of wallet, continued M&A

    Market and share growth Grow share of wallet Continued M&A Opportunity: increase conversion, Opportunity: Expand to new markets Opportunity: Further strengthen our profit per visit, higher output from with new products, increase share of capabilities, scale and service scope + limited resources, inc

  5. Slide 5: Investments in usability, Google visibility and marketing optimization

    Investments in usability, Google Improvement in web booking Clear y-o-y increase in visibility, and marketing user experience is reflected in self-service rates optimization have increased higher conversion rate vs. last visits y-o-y year Change Q1/21 vs. Q1/20 5

  6. Slide 6: Strong strategic fit: Customer's health partner and the smartest platform

    • Health awareness is a strong, growing trend. Consumers are increasingly interested in utilizing measurable data about their own health. • We are changing the industry standards by taking a proactive role in promoting customer health and bringing science into wellness services. • The cooperation is

  7. Slide 7: Building health partnership between customers and Terveystalo

    Holistic well-being measurement Digital lifestyle coaching package Regular measurements with Nightingale’s technology give A set of digital lifestyle coaching and research-based tools to information about customer’s health and encourage lifestyle increase customer’s own well-being. change. Guidance

  8. Slide 8: Latest acquisitions

    Internationally scalable Cost synergies & scale Growth in new services Capabilities that support our Segments where we have a Niche players in specialized strategy delivery, e.g. Evalua small market share, such as fields dental, physio, mental health Expanding the markets Latest acquisitions: Helsin

  9. Slide 9: Outlook – The next 6 months vs. last 6 months

    Outlook – The next 6 months vs. last 6 months Market environment • In the short term, the market environment is still uncertain because of the changes in consumer behavior resulting from the COVID- 19 pandemic, and predicting demand is challenging in the short term. • Demand for coronavirus testing

  10. Slide 10: Ilkka Laurila, CFO – Financial performance

    IIkka Laurila, CFO Financial performance Terveystalo

  11. Slide 11: Q1/21 revenue by payer group

    Q1/21 revenue by payer group, % Q1/21 revenue by payer group, M€ 8.3% 300 279 257 23 26% 250 16 21 21 29 200 29 44% 82 150 80 100 111 123 50 29% 0 Q1 2020 Q1 2021 Corporate Public Corporate Staffing services Private Private Service sales, OH and others 11 Outsourcing

  12. Slide 12: Wellbeing sales and digital visits

    WELLBEING SALES, M€ DIGITAL VISITS, THOUSANDS +16% +96% +10% +281% 30 250 +9% -7% +282% 25 200 20 +271% 150 15 100 10 50 5 0 0 2018 2018 2018 2018 2019 2019 2019 2019 2020 2020 2020 2020 2021 Q4 2018 Q1 Q2 Q3 Q4 Q1 2020 Q2 Q3 2020 Q4 Q1 2021 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 2019 2019 2019 2019

  13. Slide 13: Revenue, adjusted EBITDA and adjusted EBITA

    REVENUE M €, ADJUSTED EBITDA * ** % ADJUSTED EBITA* ** M€ AND % Revenue Adjusted EBITA, M€ * Alternative key figure 13 ** The figures include the effect of IFRS Adjusted EBITDA % Adjusted EBITA, % 16 from 2019 onwards

  14. Slide 14: Income statement

    M€ 1-3/2021 1-3/2020 Change % 2020 Revenue 278,7 257,4 8,3 986,4 Other operating income 0,5 0,9 -43,7 2,7 Purchase of materials -8,8 -9,2 -4,7 -35,5 Change in inventories 0,0 0,4 -95,0 1,3 External services -111,4 -111,1 0,2 -413,4 Employee benefit expenses -86,7 -82,7 4,8 -310,2 Rents. leases and p

  15. Slide 15: Balance sheet and net debt

    m€ 31.03.2021 31.03.2020 31.12.2020 ASSETS • Cash and cash equivalents EUR 86.7 (51.5) million Property. plant and equipment 67,0 70,4 67,6 Right of use assets 168,2 187 172,4 • Total assets EUR 1,381.7 (1,361.3) million Goodwill 786,1 779,7 781,8 Other intangible assets 149,8 158,5 152,2 • Equity a

  16. Slide 16: Net debt/adjusted EBITDA and net working capital

    NET DEBT/ADJUSTED EBITDA OPERATIONAL EFFICIENCY IS REFLECTED IN THE (LAST 12 MONTHS)* NEGATIVE NET WORKING CAPITAL 4,6 4,1 -15,6% 6 6 6 6 6 8 7 8 7 3,5 3,4 3,4 3,1 3,2 110 101 101 102 100 99 95 109 3,0 83 2,7 -58 -59 -58 -52 -61 -57 -70 -73 -86 -174 -176 -166 -165 -179 -177 -159 -163 -173 Q1 Q2 Q3 Q

  17. Slide 17: DSO and DPO, rolling 3 months

    DSO, ROLLING 3 MONTHS DPO, ROLLING 3 MONTHS -4,3% -3,6% 32,5 32,0 32,3 32,3 58,5 57,5 56,4 30,1 30,9 30,5 30,9 54,2 28,9 53,4 48,7 49,3 49,1 50,6 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 2019 2019 2019 2019 2020 2020 2020 2020 2021 2019 2019 2019 2019 2020 2020 2020 2020 2021 DSO= Days

  18. Slide 18: Gross capex and net capex

    GROSS CAPEX, M€ AND %- OF REVENUE NET CAPEX, M€ AND %- OF REVENUE 18

  19. Slide 19: Upcoming financial reports

    • Half-Year Report for January-June 2021 on Friday, 16 July 2021 • Interim report for January-September 2021 on Thursday, 28 October 2021

  20. Slide 20: Q&A

    / Lf \ Terveystalo Q&A

  21. Slide 21: Terveystalo

    y lerveystald

  22. Slide 22: Terveystalo Group key figures, EUR million

    1-3/ 1-3/ Change, Terveystalo Group, EUR million 2020 2021 2020 % Revenue 278,7 257,4 8,3 986,4 Adjusted EBITDA * 1) 53,3 38,2 39,6 162,8 Adjusted EBITDA, % * 1) 19,1 14,8 - 16,5 EBITDA 1) 53,2 35,9 48,3 158,3 EBITDA, % 1) 19,1 13,9 - 16,1 Adjusted earnings before interest. taxes and amortization (E

  23. Slide 23: Personnel, net debt and quality indicators

    Average personnel in person-years 5 170 5 051 2,3 4 900 Personnel (end of period) 8 427 8 711 -3,3 8 253 Private practitioners (end of period) 5 051 5 132 -1,6 5 057 Adjusted EBITDA, excluding IFRS 16 *1) 133,1 121,7 9,4 118,0 Net debt, excluding IFRS 16 302,6 338,3 -10,6 312,4 Adjusted net debt/ ad

  24. Slide 24: Terveystalo

    Terveystalo Kohti parempaa. ©0000 ¢f

Terveystalo — Q1 2021 Earnings Presentation on 6ix